Royal Bank Of Canada Lowers HCA Healthcare (NYSE:HCA) Price Target to $401.00

HCA Healthcare (NYSE:HCA) had its target price decreased by Royal Bank Of Canada from $404.00 to $401.00 in a note issued to investors on Monday, MarketBeat Ratings reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 13.20% from the company’s current price.

HCA has been the subject of several other reports. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Bank of America lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 price objective on the stock. in a research note on Wednesday, July 16th. Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Robert W. Baird reiterated a “neutral” rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research note on Monday. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $396.46.

HCA Healthcare Price Performance

Shares of HCA traded down $0.82 during mid-day trading on Monday, hitting $354.24. 1,462,678 shares of the company were exchanged, compared to its average volume of 1,533,991. The stock has a market cap of $85.22 billion, a price-to-earnings ratio of 14.89, a price-to-earnings-growth ratio of 1.12 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a 50 day moving average of $371.51 and a 200-day moving average of $346.46.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm earned $5.50 EPS. HCA Healthcare’s quarterly revenue was up 6.4% on a year-over-year basis. Analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company’s stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

Institutional Trading of HCA Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter worth about $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the first quarter worth about $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare in the second quarter worth about $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.